Krynica Vitamin S.A. (WSE:KVT)

Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 159.26 million. The enterprise value is 181.17 million.

Market Cap	159.26M
Enterprise Value	181.17M

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	Jun 29, 2026

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding.

Current Share Class	12.25M
Shares Outstanding	12.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 13.43.

PE Ratio	13.43
Forward PE	n/a
PS Ratio	0.44
PB Ratio	1.54
P/TBV Ratio	1.60
P/FCF Ratio	7.57
P/OCF Ratio	4.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.70, with an EV/FCF ratio of 8.61.

EV / Earnings	15.28
EV / Sales	0.50
EV / EBITDA	4.70
EV / EBIT	7.48
EV / FCF	8.61

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.28.

Current Ratio	0.96
Quick Ratio	0.55
Debt / Equity	0.28
Debt / EBITDA	0.74
Debt / FCF	1.36
Interest Coverage	13.34

Financial Efficiency

Return on equity (ROE) is 11.95% and return on invested capital (ROIC) is 15.66%.

Return on Equity (ROE)	11.95%
Return on Assets (ROA)	6.76%
Return on Invested Capital (ROIC)	15.66%
Return on Capital Employed (ROCE)	20.29%
Weighted Average Cost of Capital (WACC)	4.87%
Revenue Per Employee	1.03M
Profits Per Employee	33,877
Employee Count	350
Asset Turnover	1.62
Inventory Turnover	6.80

Taxes

In the past 12 months, Krynica Vitamin has paid 2.39 million in taxes.

Income Tax	2.39M
Effective Tax Rate	16.79%

Stock Price Statistics

The stock price has increased by +32.65% in the last 52 weeks. The beta is 0.10, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+32.65%
50-Day Moving Average	12.25
200-Day Moving Average	10.82
Relative Strength Index (RSI)	57.58
Average Volume (20 Days)	481

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 362.02 million and earned 11.86 million in profits.

Revenue	362.02M
Gross Profit	62.30M
Operating Income	24.22M
Pretax Income	14.25M
Net Income	11.86M
EBITDA	38.58M
EBIT	24.22M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 6.76 million in cash and 28.67 million in debt, with a net cash position of -21.92 million or -1.79 per share.

Cash & Cash Equivalents	6.76M
Total Debt	28.67M
Net Cash	-21.92M
Net Cash Per Share	-1.79
Equity (Book Value)	103.49M
Book Value Per Share	n/a
Working Capital	-4.83M

Cash Flow

In the last 12 months, operating cash flow was 31.97 million and capital expenditures -10.92 million, giving a free cash flow of 21.05 million.

Operating Cash Flow	31.97M
Capital Expenditures	-10.92M
Depreciation & Amortization	14.35M
Net Borrowing	-9.42M
Free Cash Flow	21.05M
FCF Per Share	1.72

Margins

Gross margin is 17.21%, with operating and profit margins of 6.69% and 3.28%.

Gross Margin	17.21%
Operating Margin	6.69%
Pretax Margin	3.94%
Profit Margin	3.28%
EBITDA Margin	10.66%
EBIT Margin	6.69%
FCF Margin	5.81%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.08%.

Dividend Per Share	0.27
Dividend Yield	2.08%
Dividend Growth (YoY)	129.63%
Years of Dividend Growth	1
Payout Ratio	27.90%
Buyback Yield	n/a
Shareholder Yield	2.08%
Earnings Yield	7.45%
FCF Yield	13.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6